This systemic effect is at least in part associated with circulating EVs that increase their HDAC1 cargo following ischemia training, leading to reprogramming of the BM-Mono by downregulating Dhcr24 gene expression in recipient cells. The gene discussed is HDAC1; the disease is ischemia.